tiprankstipranks
Trending News
More News >
GenSight Biologics (DE:G49N)
:G49N

GenSight Biologics SA (G49N) Revenue

Compare
1 Followers

GenSight Biologics SA Revenue

GenSight Biologics SA had a revenue of 897.00K in the quarter ending Dec 31, 2024, with -48.09%. This bring the company's revenue in the last twelve months to 2.63M, Decreased 32.84%. In the fiscal year ending Dec 31, 2024, GenSight Biologics SA had annual revenue of 2.63M with 107.18% growth.
Revenue (ttm)
2.63M
Revenue Growth
P/S Ratio
10.17
Revenue/Employee
€164,063
Employees
16
Market Cap
€26.69M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.63M1.36M+107.18%
Dec 31, 2023
1.27M-1.31M-50.93%
Dec 31, 2022
2.58M-2.69M-51.06%
Dec 31, 2021
5.28M882.00K+20.07%
Dec 31, 2020
4.39M3.69M+527.71%
Dec 31, 2019
700.00K-3.65M-83.89%
Dec 31, 2018
4.35M644.00K+17.40%
Dec 31, 2017
3.70M701.00K+23.36%
Dec 31, 2016
3.00M-559.00K-15.70%
Dec 31, 2015
3.56M2.46M+222.85%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis